TY - JOUR
T1 - Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome)
AU - Antshel, Kevin M.
AU - Conchelos, Jena
AU - Lanzetta, Gabrielle
AU - Fremont, Wanda
AU - Kates, Wendy R.
N1 - Funding Information:
This work was supported by NIH grants MH64824 and MH65481 to Wendy Kates. The authors are grateful to Robert J. Shprintzen, Ph.D., Anne Marie Higgins, N.P., and the children and families who participated.
PY - 2005/4/30
Y1 - 2005/4/30
N2 - Velocardiofacial syndrome (VCFS) is a neurodevelopmental disorder caused by a microdeletion on chromosome 22q11.2 that predisposes affected individuals to learning disabilities and psychiatric conditions. Previous research has indicated that compared with comparison children, children with VCFS have larger corpus callosal areas. Children with VCFS are often diagnosed with comorbid attention deficit hyperactivity disorder (ADHD), and previous research has indicated that children with ADHD often have smaller corpus callosal areas than controls. The present study investigated two hypotheses: children with VCFS would have larger callosal areas than controls, and children with VCFS + ADHD would have smaller callosal areas than children with VCFS. Corpus callosum area was obtained from the mid-sagittal slice and was assessed in children with VCFS (n=60) and age- and gender-matched control participants (n = 52). Results indicated that all of the corpus callosum measures were significantly different between the two groups except for the genu. Across all measures, children with VCFS demonstrated a larger corpus callosum area. Within the VCFS sample, children with VCFS + ADHD (n = 30) had smaller total callosal, splenium, and genu areas than children with VCFS alone. Although children with VCFS + ADHD had smaller total callosal areas than children with VCFS, relative to control participants, these children had larger total callosal and subregion areas except for the genu. In addition to other anatomic anomalies, corpus callosal abnormalities appear to be another variable to consider when analyzing brain/behavior relations in this population.
AB - Velocardiofacial syndrome (VCFS) is a neurodevelopmental disorder caused by a microdeletion on chromosome 22q11.2 that predisposes affected individuals to learning disabilities and psychiatric conditions. Previous research has indicated that compared with comparison children, children with VCFS have larger corpus callosal areas. Children with VCFS are often diagnosed with comorbid attention deficit hyperactivity disorder (ADHD), and previous research has indicated that children with ADHD often have smaller corpus callosal areas than controls. The present study investigated two hypotheses: children with VCFS would have larger callosal areas than controls, and children with VCFS + ADHD would have smaller callosal areas than children with VCFS. Corpus callosum area was obtained from the mid-sagittal slice and was assessed in children with VCFS (n=60) and age- and gender-matched control participants (n = 52). Results indicated that all of the corpus callosum measures were significantly different between the two groups except for the genu. Across all measures, children with VCFS demonstrated a larger corpus callosum area. Within the VCFS sample, children with VCFS + ADHD (n = 30) had smaller total callosal, splenium, and genu areas than children with VCFS alone. Although children with VCFS + ADHD had smaller total callosal areas than children with VCFS, relative to control participants, these children had larger total callosal and subregion areas except for the genu. In addition to other anatomic anomalies, corpus callosal abnormalities appear to be another variable to consider when analyzing brain/behavior relations in this population.
KW - 22q11 deletion
KW - ADHD
KW - Corpus callosum
KW - Developmental disorder
KW - Neuroimaging
KW - Velocardiofacial syndrome (VCFS)
UR - http://www.scopus.com/inward/record.url?scp=18044377629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18044377629&partnerID=8YFLogxK
U2 - 10.1016/j.pscychresns.2005.02.003
DO - 10.1016/j.pscychresns.2005.02.003
M3 - Article
C2 - 15854791
AN - SCOPUS:18044377629
SN - 0925-4927
VL - 138
SP - 235
EP - 245
JO - Psychiatry Research - Neuroimaging
JF - Psychiatry Research - Neuroimaging
IS - 3
ER -